6-Hydroxy- and 6-methoxy-β-carbolines as acetyl- and butyrylcholinesterase inhibitors
Authors:
- Michael DeckerMDMichael Decker
- Hans RommelspacherHRHans Rommelspacher
- Jochen LehmannJLJochen Lehmann
- 1 November 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (22) , 5840-5843
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpineEuropean Journal of Medicinal Chemistry, 2005
- Phenylethanolamine N-methyltransferase has β-carboline 2N-methyltransferase activity: hypothetical relevance to Parkinson’s diseaseNeurochemistry International, 2002
- Endogenously Occurring β‐Carboline Induces Parkinsonism in Nonprimate Animals: A Possible Causative Protoxin in Idiopathic Parkinson's DiseaseJournal of Neurochemistry, 1998
- beta-Carbolinium cations, endogenous MPP plus analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's diseaseNeurology, 1995
- Electrochemistry of natural products. 7. Oxidative decarboxylation of some tetrahydro-.beta.-carbolinecarboxylic acidsThe Journal of Organic Chemistry, 1980
- Naturally Occurring and Synthetic β-Carbolines as Cholinesterase InhibitorsJournal of Pharmaceutical Sciences, 1972
- Inhibitors of Monoamine OxidaseJournal of Pharmaceutical Sciences, 1968
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961